SCHEMBL687274

SCHEMBL687274

CCC[C@H](O)CCN(CC(C)(C)NC(=O)CN)C(=O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
RECQL P46063 1/20 0.38
CCR6 P51684 1/20 0.38
PAX8 Q06710 1/20 0.38
MAPK1 P28482 1/20 0.38
ABCB1 P08183 1/20 0.35
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
LTA4H P09960 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CTSK P43235 1/20 0.34
SYK P43405 1/20 0.33
CCR5 P51681 1/20 0.33
EPOR P19235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686798 0.84 CCR6 (0.40) CYP3A4CCR6PAX8MAPK1ABCB1
SCHEMBL25449194 0.69 CCR6 (0.46) MAPTKMT2ACYP3A4CCR6PAX8
SCHEMBL21012224 0.69 CCR6 (0.46) MAPTKMT2ACYP3A4CCR6PAX8
SCHEMBL12023054 0.68 CCR6 (0.47) KMT2ACYP3A4CCR6PAX8MAPK1
SCHEMBL3083608 0.68 CCR6 (0.58) MAPTKMT2ACYP3A4CCR6PAX8
Carbamic Acid SCHEMBL25282587 0.67 CCR6 (0.55) MAPTKMT2ACYP3A4CCR6PAX8
Hydrochloric Acid SCHEMBL11685224 0.66 MAPK1 (0.55) KDM4EMEN1MAPTKMT2ACYP1A2
SCHEMBL565993 0.66 CCR6 (0.44) MEN1MAPTKMT2ACCR6PAX8
SCHEMBL1328808 0.66 CCR6 (0.50) MAPTKMT2ACYP3A4CCR6PAX8
SCHEMBL14476880 0.65 CCR6 (0.63) MAPTKMT2ACYP3A4CCR6PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667966-B1 N-ALKYLATED DIAMINOPROPANE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2012-02-29 EP disclosed